We are focused on accelerating the delivery of life-changing medicines that create enduring value for people, society and the planet.
We aim to drive positive change beyond the impact of our medicines by embedding sustainability into everything we do – from the lab to the patient.
As a responsible, ethical global company, we are tackling the biggest sustainability challenges of our time, including the climate crisis, biodiversity loss, health equity and health system resilience. These are interconnected and require collaboration within and beyond the health sector.
*as at end December 2023, source: Sustainability Report 2023
To address health equity and achieve affordable, sustainable and innovative care for all, we’re increasing access to medicines and strengthening health systems through sustainable initiatives, industry and community partnerships.
Through collaboration, engaging with our suppliers, and managing the environmental impact and emissions of our own operations, we're tackling the climate crisis by decarbonising our value chain and accelerating the delivery of net-zero healthcare. We’re also promoting biodiversity and building ecological and community resilience.
We’re creating positive impact on society and behaving with transparency across our value chain, promoting ethical, inclusive and diverse policies and initiatives, including with our partners and suppliers.
Sustainable science – from the lab to the patient
ArticleWe strive to accelerate the delivery of sustainable healthcare by embedding sustainable practices into the design, development and delivery of our life-changing medicines.
